Oxford Vaccine Group and Pandemic Sciences Institute\u2019s Professor Pollard speaks to the people who shaped the COVID-19 pandemic in his new podcast, The Oxford Colloquy.
Abstract submission for the International Pandemic Sciences Conference 2023 - Making the Exceptional Routine has been extended to Friday 28 April 2023.
A new Future Vaccines Manufacturing Hub \u2013 co-led by University of Oxford and University College London \u2013 aims to make the UK the global centre for discovering and manufacturing next-generation vaccines.
Professor Dame Sarah Gilbert has been awarded the prestigious King Faisal Prize in recognition of her work to co-create a COVID-19 vaccine that has saved an estimated six million lives.
The Pandemic Sciences Institute and the UK's Defence Science and Technology Laboratory (Dstl) have agreed to jointly study the dangerous pathogens that could cause future pandemics.
A team of experts at the Pandemic Sciences Institute at the University of Oxford and Department of Statistics at the University of Warwick estimate the NHS COVID-19 app prevented around 1 million cases, 44,000 hospitalisations and 9,600 deaths during its first year.
The Pandemic Sciences Institute announces a new partnership with the Royal Veterinary College to facilitate collaborative research into infectious diseases.
A vaccine scientist from the University of Oxford recently received the prestigious Presidential Distinguished Service Award for the Irish Abroad for 2022, which recognises the contribution of members of the Irish diaspora.
Professor Dame Sarah Gilbert, the Sa\u00efd Chair of Vaccinology in the Nuffield Department of Medicine has been selected to receive King Faisal Prize for Medicine for 2023, along with Professor Dan Barouch of Harvard Medical School.
Here at VaccineNation we are delighted to kickstart the new year with another one of our recorded interviews from the World Vaccine Congress in Europe. As we look forward to the Congress in Washington in April, we will be releasing further interviews and exploring key themes for the event. For this interview we were lucky to secure a slot with Professor Miles Carroll of Oxford University. A specialist in high consequence emerging viral infections, his insight into how we respond to new threats and prepare for the future is incredibly exciting!
During the first lockdown in early 2020, an emergency Coronavirus Research Fund was set up to channel the huge amounts of gifts that started pouring in, and to direct them quickly to the research projects that had the biggest chance of mitigating the worst effects of the pandemic.
The inaugural MRC Impact Prize recognises teams who have made outstanding impacts in health and medical research. The winners will be announced at a ceremony in the spring.
A vaccine developed by the Oxford Vaccine Group\u2019s Prof Teresa Lambe and supported in clinical trials and manufacture scale-up by researchers from the Jenner Institute (Nuffield Department of Medicine) has been recommended for inclusion in a ring vaccination trial to combat a Sudan ebolavirus outbreak in Uganda.
The Rockefeller Foundation has announced $3 million in new funding for Global.health (G.h) \u2013 a first-of-its-kind, open-source platform for scientific pandemic data. This will enable it to expand its international partnerships and modernize the global effort around coordinated pandemic prevention, surveillance, and response.
The Pandemic Sciences Institute is hosting the UK GOARN partners this week to discuss hot topics such as operational research and rapid response capacity during outbreaks.
The UK\u2019s efforts to tackle the monkeypox outbreak will receive a huge boost with the creation of a new research consortium \u2013 in which the University of Oxford is a key partner \u2013 working together to develop better diagnostic tests, identify potential therapies and study vaccine effectiveness.
The team behind the world-leading RECOVERY trial of COVID-19 treatments are leading a new study investigating a potential treatment for people who have been diagnosed with monkeypox. The National Institute for Health and Care Research (NIHR) has commissioned and funded the study. The first patients have now been recruited.
Each year, the Royal Society recognises exceptional research achievements through a series of prestigious medals and prizes named after great scientists of the past. Eight of the 2021-22 awards, announced today, honour Oxford University researchers for their outstanding contributions to science and medicine.
![\"Professor](\"https://www.psi.ox.ac.uk/news-and-opinion/professor-sir-andrew-pollard-reveals-unique-insights-into-the-world-of-science-in-a-new-podcast/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n